Use of novel radiosensitizers and radiation-specific miRNAs to modulate radiation response in non-small cell lung adenocarcinoma (NSCLC).
2010
e17519 Background: Tumor response to radiotherapy in NSCLC remains markedly heterogeneous. Few successful radiosensitivity predictive assays exist that can be applied to individualize radiotherapeutic options. Methods: Using Bayesian regression analysis, a 52-gene expression signature that predicts sensitivity to external beam radiotherapy was developed and independently validated. On the basis of the signature, using Connectivity Map, novel candidate radiosensitizers were identified and tested in vitro by cell proliferation assays on predicted radioresistant NSCLC cell lines at three different radiation doses (3, 5 and 7 Gy). Cisplatin was used as a clinically relevant control. Furthermore, a systemic computational approach was developed to identify potential radiation-specific miRNAs, which were later transiently expressed and validated in vitro using the aforementioned NSCLC cell lines. Results: The 52-gene expression signature accurately predicted radiosensitivity in vitro and in individuals treated w...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI